[ Price : $8.95]
The Government Accountability Office tells HHS secretary Robert F. Kennedy, Jr., about priority recommendations it has made in the...[ Price : $8.95]
FDA warns Malaysias BioAsia Worldwide about CGMP violations in its production of finished drugs, some of which may be regulated as...[ Price : $8.95]
Cytokinetics reports topline results from its Phase 3 MAPLE-HCM clinical trial showing that aficamten significantly improved exerc...[ Price : $8.95]
FDA accepts for priority review a Regenxbio BLA seeking accelerated approval for gene therapy RGX-121 (clemidsogene lanparvovec) f...[ Price : $8.95]
FDA sends Indian active pharmaceutical ingredient manufacturer Mentha & Allied Products a Warning Letter that cites the firm for s...[ Price : $8.95]
FDA and HHS ask public stakeholders for their ideas on regulations that should be eliminated.[ Price : $8.95]
FDA warns Frances Excelvision Fareva about CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA plans to remove from the market concentrated ingestible fluoride prescription drug products for children, citing safety concer...